Koutif Therapeutics
PrivateLast Round
Accelerator
Sep 21, 2017
Company Overview
Koutif Therapeutics is a biotechnology company that develops therapeutic compounds targeting the ubiquitin degradation pathway to treat various inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Koutif Therapeutics Comparables
Compare Koutif Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kymera Therapeutics, Inc. | 73% | |
| GluBio Therapeutics | 72% | |
| Nurix Therapeutics, Inc. | 68% |
Koutif Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 21, 2017 |
Koutif Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMotiv | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2017
Led by BioMotiv
Koutif Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Koutif Therapeutics's valuation, stock price, and market status.
Is Koutif Therapeutics a public or private company?
Koutif Therapeutics is a private company.
What is the current stock price of Koutif Therapeutics?
Koutif Therapeutics is a private company, so its shares have no public market price. Caplight tracks Koutif Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Koutif Therapeutics worth (valuation)?
Valuation information for Koutif Therapeutics is not publicly available.
Can I buy Koutif Therapeutics stock?
Koutif Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Koutif Therapeutics's last funding round?
Koutif Therapeutics's most recent funding round was Accelerator on September 21, 2017.
Who are the main investors in Koutif Therapeutics?
Key investors in Koutif Therapeutics include BioMotiv.
Will Koutif Therapeutics IPO soon?
No public IPO plans have been announced for Koutif Therapeutics.
How can I track Koutif Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Koutif Therapeutics's shares on secondary markets.